Fusion Pharmaceuticals Inc. Receivables, Net, Current
Fusion Pharmaceuticals Inc. had Receivables, Net, Current of $7.00 thousand as of 2023-12-31, per its 10-Q filed 2024-05-07.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:ReceivablesNetCurrent · last filed 2024-05-07
- 2023-12-31: Receivables, Net, Current $7.00K.
- 2023-09-30: Receivables, Net, Current $41.00K.
- 2023-06-30: Receivables, Net, Current $62.00K.
- 2023-03-31: Receivables, Net, Current $89.00K.
| Period end | Receivables, Net, Current |
|---|---|
| 2023-12-31 | $7.00K 10-Q · filed 2024-05-07 |
| 2023-09-30 | $41.00K 10-Q · filed 2023-11-07 |
| 2023-06-30 | $62.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $89.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $61.00K 10-K · filed 2024-03-20 |
| 2022-09-30 | $215.00K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $177.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $325.00K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $357.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | $300.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $121.00K 10-Q · filed 2021-08-10 |